There is a comment about CGM and here it is:
We continue to make progress with our next generation pod and with the version of our PDM which will provide integrated continuous glucose monitoring capabilities. We remain on track to be into the FDA by year end, with an integrated CGM solution.
And later in the call:
Ben Andrew – William Blair
Good. Last quick question, you mentioned you have a CGM going to the FDA by the end of the year, I assume that's with Abbott with DexCom.
Brian Roberts
Yes, one of those two.
Ben Andrew – William Blair
Are you not disclosing or…?
Brian Roberts
Yes, look at the end of the day, we have agreements in place with both and we are charging ahead with both of them.
Here is another interesting comment on Pod for non diabetes use:
We are also advancing our efforts to outside the diabetes. The request for CE Mark approval has been filed ahead of schedule for our first non-diabetes application and partnership with Ferring Pharmaceuticals. We expect to receive approval this quarter.
No comments :
Post a Comment